Early CD4+ T-Cell Reconstitution Is an Excellent Predictor for Survival and Non-Relapse Mortality in Pediatric and Young Adult Patients Who Develop Moderate to Severe Acute Graft-Versus-Host-Disease; A Dual Center Validation
Coco de Koning(University Medical Center Utrecht), Jaap Jan Boelens(Wilhelmina Children's Hospital), Maria Cancio(Memorial Sloan Kettering Cancer Center), Caroline A. Lindemans(University Medical Center Utrecht), Susan E. Prockop(Memorial Sloan Kettering Cancer Center), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Barbara Spitzer(Memorial Sloan Kettering Cancer Center), Birgitta Versluys(University Medical Center Utrecht), Farid Boulad(Memorial Sloan Kettering Cancer Center), Nancy A. Kernan(Memorial Sloan Kettering Cancer Center), Marc Bierings(University Medical Center Utrecht), Andromachi Scaradavou(NewYork–Presbyterian Hospital), Stefan Nierkens(Utrecht University), Richard J. O’Reilly(Memorial Sloan Kettering Cancer Center), Ichelle van Roessel(Memorial Sloan Kettering Cancer Center), Elizabeth Klein(Memorial Sloan Kettering Cancer Center)
Cited by 3
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
|New England Journal of Medicine|1993|848
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739